A method of treating skin by reducing tumor necrosis factor alpha (TNF-α) activity or matrix metalloproteinase enzyme (MMP-1) activity in a person's skin is disclosed. The method can include topically applying a composition that includes an effective amount of an extract of Brachychiton acerifolius to the person's skin to reduce TNF-α activity or MMP-1 activity in the skin.